Liaoyuan Yulongdongya Pharmaceutical Co., Ltd. Report issue

Government Phase 4

Organization Overview

First Clinical Trial
2017
NCT03175900
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now